Page 80 - 2020年1月第31卷第2期
P. 80

二甲双胍对胰腺癌BxPC-3细胞恶性表型的影响                                                   Δ



               *
        黄志铨 ,王振文,朱 亮(南昌大学第一附属医院消化内科,南昌 330006)
                               #
        中图分类号 R965          文献标志码 A           文章编号 1001-0408(2020)02-0202-06
        DOI   10.6039/j.issn.1001-0408.2020.02.14

        摘   要   目的:探索二甲双胍对胰腺癌BxPC-3细胞恶性表型的影响。方法:以Smad4基因天然缺失型人胰腺癌BxPC-3细胞为对
        象,采用CCK-8法和流式细胞术分别检测不同剂量二甲双胍(5、10、20 mmol/L)作用24 h后的细胞增殖和凋亡情况,并计算细胞存
        活率和凋亡率;采用Transwell迁移试验检测不同剂量二甲双胍(10、20 mmol/L)作用24 h后的细胞迁移情况,记录迁移细胞数;采
        用实时定量聚合酶链反应法和Western blotting法分别检测细胞中钙黏着蛋白E(E-cadherin)、波形蛋白(Vimentin)、补体反应基因
        32(RGC-32)的mRNA及蛋白表达情况。结果:与对照组和5 mmol/L二甲双胍组比较,10、20 mmol/L二甲双胍组细胞的存活率均
        显著降低,凋亡率均显著升高,且 20 mmol/L 二甲双胍组细胞的凋亡率显著高于 10 mmol/L 二甲双胍组(P<0.05)。与对照组比
        较,10、20 mmol/L 二甲双胍组迁移细胞数均显著减少,且 20 mmol/L 二甲双胍组显著少于 10 mmol/L 二甲双胍组(P<0.05);10、
        20 mmol/L二甲双胍组细胞中E-cadherin mRNA及其蛋白的相对表达量均显著升高,且20 mmol/L二甲双胍组E-cadherin mRNA
        的相对表达量显著高于10 mmol/L二甲双胍组;10 mmol/L二甲双胍组细胞中Vimentin mRNA,20 mmol/L二甲双胍组细胞中Vi-
        mentin mRNA 及其蛋白以及 10、20 mmol/L二甲双胍组细胞中 RGC-32 mRNA 及其蛋白的相对表达量均显著降低,且 20 mmol/L
        二甲双胍组Vimentin mRNA及其蛋白、RGC-32 mRNA的相对表达量均显著低于10 mmol/L二甲双胍组(P<0.05或P<0.01)。结
        论:二甲双胍可剂量依赖性地通过Smad4非依赖性通路抑制BxPC-3细胞的增殖和迁移,促进其凋亡,这可能与胰腺癌细胞上皮间
        质转化过程以及RGC-32表达受到抑制有关。
        关键词 二甲双胍;胰腺癌;BxPC-3细胞;增殖;凋亡;上皮间质转化;补体反应基因32

        Effects of Metformin on the Malignant Phenotype of Pancreatic Cancer BxPC-3 Cells
        HUANG Zhiquan,WANG Zhenwen,ZHU Liang(Dept. of Gastroenterology,the First Affiliated Hospital of
        Nanchang University,Nanchang 330006,China)

        ABSTRACT    OBJECTIVE:To investigate the effects of metformin on malignant phenotype of pancreatic cancer BxPC-3 cells.
        METHODS:Using human pancreatic cancer BxPC-3 cells with natural deletion of Smad4 gene as reaserch objects,CCK-8 assay
        and flow cytometry were used to detect the proliferation and apoptosis of BxPC-3 cells after treated with different doses of
        metformin(5,10,20 mmol/L)for 24 h. The cell survival rate and apoptosis rate were calculated. Transwell assay was used to test
        the migration of cells after treated with different doses of metformin(10,20 mmol/L)for 24 h. The number of migrating cells was
        recorded. qRT-PCR and Western blotting assay were performed to determine mRNA and protein expression of E-cadherin,Vimentin
        and RGC-32 in cells. RESULTS:Compared with control group and 5 mmol/L metformin group,survival rate of cells were
        decreased significantly in 10,20 mmol/L metformin groups,while apoptosis rate was increased significantly;the apoptosis rate in
        20 mmol/L metformin group was significantly higher than 10 mmol/L metformin group(P<0.05). Compared with control group,
        the number of migrating cells was decreased significantly in 10,20 mmol/L metformin groups,and the 20 mmol/L metformin
        group was significantly lower than 10 mmol/L metformin group(P<0.05). Relative mRNA and protein expression of E-cadherin
        were increased significantly in 10,20 mmol/L metformin groups,and relative mRNA expression of E-cadherin in 20 mmol/L
        metformin group was significantly higher than 10 mmol/L metformin group. Relative mRNA expression of Vimentin in 10 mmol/L
        metformin group,relative mRNA and protein expression of Vimentin in 20 mmol/L metformin group,relative mRNA and protein
        expression of RGC-32 in 10,20 mmol/L metformin groups were decreased significantly;relative mRNA and protein expression of
        Vimentin as well as mRNA expression of RGC-32 in 20 mmol/L metformin group were significantly lower than 10 mmol/L
        metformin group (P<0.05 or P<0.01). CONCLUSIONS:Metformin can inhibit the proliferation and migration of pancreatic
                                                            cancer cells through smael-independent pathways in a dose-
            Δ 基金项目:江西省青年科学基金资助项目(No.20171BAB215044);
                                                            dependent manner, and promote their apoptosis, which is
        江西省教育厅科学技术研究项目(No.170006);江西省卫生计生委科
                                                            associated with the inhibition epithelial-mesenchymal transition
        技计划项目(No.20195082)
            *硕士研究生。研究方向:胰腺癌的侵袭和转移机制。电话:                     and the expression of RGC-32 of pancreatic cancer.
        0791-88694228。E-mail:hzq4010@163.com                KEYWORDS     Metformin;Pancreatic cancer;BxPC-3 cell;
            # 通信作者:副主任医师,硕士生导师,博士。研究方向:胰腺癌                  Proliferation; Apoptosis; Epithelial-mesenchymal transition;
        的侵袭和转移机制。电话:0791-88694228。E-mail:89493075@qq.       RGC-32
        com


        ·202  ·  China Pharmacy 2020 Vol. 31 No. 2                                   中国药房    2020年第31卷第2期
   75   76   77   78   79   80   81   82   83   84   85